chr2-31525043-T-TAA
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_000348.4(SRD5A2):c.*1152_*1153insTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 190,274 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 32)
Exomes 𝑓: 0.014 ( 0 hom. )
Consequence
SRD5A2
NM_000348.4 3_prime_UTR
NM_000348.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.414
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0016 (226/141308) while in subpopulation SAS AF= 0.0435 (193/4438). AF 95% confidence interval is 0.0385. There are 2 homozygotes in gnomad4. There are 163 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRD5A2 | NM_000348.4 | c.*1152_*1153insTT | 3_prime_UTR_variant | 5/5 | ENST00000622030.2 | ||
SRD5A2 | XM_011533069.3 | c.*1152_*1153insTT | 3_prime_UTR_variant | 5/5 | |||
SRD5A2 | XM_011533072.3 | c.*1152_*1153insTT | 3_prime_UTR_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRD5A2 | ENST00000622030.2 | c.*1152_*1153insTT | 3_prime_UTR_variant | 5/5 | 1 | NM_000348.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 229AN: 141262Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
229
AN:
141262
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0140 AC: 684AN: 48966Hom.: 0 Cov.: 0 AF XY: 0.0132 AC XY: 299AN XY: 22714
GnomAD4 exome
AF:
AC:
684
AN:
48966
Hom.:
Cov.:
0
AF XY:
AC XY:
299
AN XY:
22714
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00160 AC: 226AN: 141308Hom.: 2 Cov.: 32 AF XY: 0.00238 AC XY: 163AN XY: 68484
GnomAD4 genome
AF:
AC:
226
AN:
141308
Hom.:
Cov.:
32
AF XY:
AC XY:
163
AN XY:
68484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at